Company intelligence / Profile preview

TheraNym Biologics

Hyderabad, Telangana, Indiatimesofindia.indiatimes.com ↗

Ownership: Private
Development stage: Commercial

Overview

TheraNym Biologics is building a state-of-the-art biologics manufacturing facility in Telangana, India. The company has not yet started commercial operations and had zero turnover as of March 31, 2024. It recently signed a major contract manufacturing agreement with Merck Sharpe & Dohme Singapore Trading (MSD) to produce biologicals for domestic and international markets. The facility will feature large-scale bioreactors for mammalian cell culture products and vial filling lines with an annual capacity of up to 25–30 million vials.

Modalities: BiologicMammalian cell culture biologic products
Industry: Contract Manufacturing Organization

Partnerships

Merck Sharpe & Dohme Singapore Trading Pte Ltd (MSD)

Beyond the preview

Go deeper on TheraNym Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TheraNym Biologics.

Explore the full profile